Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | METAP1 | P53582 | 1/20 | 0.37 |
| ▸ | BHMT | Q93088 | 5/20 | 0.36 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | CTSC | P53634 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | ARG1 | P05089 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Racemethionine SCHEMBL136185 | 1.00 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL30353028 | 0.98 | RNPEP (0.41) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL11750425 | 0.96 | RNPEP (0.39) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL308236 | 0.96 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL21221265 | 0.96 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL15111375 | 0.96 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL18886804 | 0.96 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL20553497 | 0.96 | — | — | |
| Racemethionine SCHEMBL5150216 | 0.96 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 | |
| Racemethionine SCHEMBL3898448 | 0.96 | RNPEP (0.42) | RNPEPANPEPENPEPMETAP2METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3400260-B2 | SCAVENGER COMPOSITIONS FOR SULFUR SPECIES | INNOPHOS INC (US) | 2025-03-19 | — | — | EP | claimed |
| EP-3359138-B1 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | PARTHENOGEN SAGL (CH) | 2024-04-24 | — | — | EP | claimed |
| WO-2023007088-A1 | FOOD SUPPLEMENT FOR COMBATING FEMALE AND MALE INFERTILITY | NURIBIOL (FR) | 2023-02-02 | — | — | WO | claimed |
| CN-115212248-A | Composition for animals with heat stress resistance and preparation method thereof | 佛山市南海东方澳龙制药有限公司 | 2022-10-21 | — | — | CN | claimed |
| EP-3400260-B1 | SCAVENGER COMPOSITIONS FOR SULFUR SPECIES | INNOPHOS INC (US) | 2021-06-02 | — | — | EP | claimed |
| US-10995280-B2 | Scavenger compositions for sulfur species | INNOPHOS, INC. (US) | 2021-05-04 | — | — | US | claimed |
| US-10966949-B2 | Dietary supplementation to achieve oxy-redox homeostasis and epigenetic stability | PARTHENOGEN SAGL (CH) | 2021-04-06 | — | — | US | claimed |
| US-10767118-B2 | Scavenger compositions for sulfur species | INNOPHOS, INC. (US) | 2020-09-08 | — | — | US | claimed |
| US-20200237701-A1 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | PARTHENOGEN SAGL (CH) | 2020-07-30 | — | — | US | claimed |
| US-20200181507-A1 | Scavenger Compositions for Sulfur Species | INNOPHOS, INC. (US) | 2020-06-11 | — | — | US | claimed |
| US-20140235569-A1 | COMPOSITION AND METHODS FOR THE PRODUCTION OF S-ADENOSYLMETHIONINE WITHIN THE BODY | FAST BALANCE, INC. (US) | 2014-08-21 | — | — | US | claimed |
| WO-2012096655-A1 | COMPOSITIONS FOR TREATING CHRONIC VIRAL INFECTIONS | ANG SAM POON (US) | 2012-07-19 | — | — | WO | claimed |
| US-20120082720-A1 | Compositions For Treating Chronic Viral Infections | ANG SAM POON (US) | 2012-04-05 | — | — | US | claimed |
| US-7985737-B2 | Compositions and methods for the regulation of homocysteine levels within the body | FAST BALANCE, INC. (US) | 2011-07-26 | — | — | US | claimed |
| US-20090239826-A1 | COMPOSITIONS AND METHODS FOR THE REGULATION OF HOMOCYSTEINE LEVELS WITHIN THE BODY | FAST BALANCE, INC. (US) | 2009-09-24 | — | — | US | claimed |
| US-7429569-B2 | Compositions and methods for the regulation of homocysteine levels within the body | FAST BALANCE, INC. (US) | 2008-09-30 | — | — | US | claimed |
| WO-2005072749-A1 | COMPOSITIONS AND METHODS FOR HOMOCSYTEINE REGULATION | HALEVIE-GOLDMAN, BRIAN, D. (US) | 2005-08-11 | — | — | WO | claimed |
| US-20050171034-A1 | Compositions and methods for the regulation of homocysteine levels within the body | FAST BALANCE, INC. (US) | 2005-08-04 | — | — | US | claimed |
| US-20040105894-A1 | Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions | GUPTA SHYAM K (US) | 2004-06-03 | — | — | US | claimed |
| US-5637324-A | Medical food composition for metabolic detoxification | METAGENICS, INC. | 1997-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235569-A1 | COMPOSITION AND METHODS FOR THE PRODUCTION OF S-ADENOSYLMETHIONINE WITHIN THE BODY | BHMT2, BHMT, AHCY | RNPEP 808/4885ANPEP 3287/4885ENPEP 1218/4885 |
| US-20120082720-A1 | Compositions For Treating Chronic Viral Infections | HAVCR2, FABP1, LIPC | RNPEP 544/4885ANPEP 1162/4885ENPEP 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.